"
Team:Wageningen UR/VLPs ProjectOverview
From 2012.igem.org
(Difference between revisions)
TSlijkhuis (Talk | contribs) (→VLPs) |
TSlijkhuis (Talk | contribs) (→VLPs) |
||
| Line 1: | Line 1: | ||
== VLPs == | == VLPs == | ||
| - | + | This year, the Wageningen UR team 2012 will work on the modification of virus-like particles (VLPs) to make them interesting platforms for vaccine production and/or site specific drug delivery. VLPs are empty virus capsids, meaning that they do not contain any viral genome, proteins and epitopes, except for the coat proteins. | |
| + | |||
| + | Three different viruses were selected to serve as a platform: Cowpea Chlorotic Mottle Virus, Hepatitis B Virus and Polerovirus. All of them bear much promise for their respective qualities. | ||
[[Team:Wageningen_UR/VLPs|Read more]] | [[Team:Wageningen_UR/VLPs|Read more]] | ||
Revision as of 07:07, 19 September 2012
VLPs
This year, the Wageningen UR team 2012 will work on the modification of virus-like particles (VLPs) to make them interesting platforms for vaccine production and/or site specific drug delivery. VLPs are empty virus capsids, meaning that they do not contain any viral genome, proteins and epitopes, except for the coat proteins.
Three different viruses were selected to serve as a platform: Cowpea Chlorotic Mottle Virus, Hepatitis B Virus and Polerovirus. All of them bear much promise for their respective qualities.
